Characteristic | Gender | Done postgraduate | ICU work | Had in-service/PG EOL training | Years of work experience | |||||
---|---|---|---|---|---|---|---|---|---|---|
Male 226 | Female 164 | Yes 162 | No 228 | Yes 122 | No 268 | Yes 107 | No 283 | < 15 years 291 | ≥ 15 99 | |
Breaking bad news | ||||||||||
Knows that doctor should break bad news to patient Q1 | 175 77.4% | 121 73.8% | 131 80.9% | 165 72.4% | 90 73.8% | 206 76.9% | 86 80.4% | 210 74.2% | 233 80.1% | 63 63.6% |
Crude OR* | 1.22 (0.76–1.95) | 1.61 (0.99–2.63) | 0.85 (0.52–1.39) | 1.42 (0.82–2.46) | 2.29 (1.39–3.79) | |||||
Adjusted OR** | – | 1.99 (1.19–3.32) | – | – | 2.71 (1.6–4.57) | |||||
Favours breaking bad news to terminally ill patient Q2 | 141 62.4% | 116 70.7% | 109 67.3% | 148 64.9% | 81 66.4% | 176 65.7% | 77 72.0% | 180 63.6% | 195 67.0% | 62 62.6% |
Crude OR* | 0.69 (0.45–1.06) | 1.1 (0.72–1.69) | 1.0 (0.66–1.62) | 1.47 (0.9–2.39) | 1.21 (0.75–1.95) | |||||
Adjusted OR** | – | – | – | – | – | |||||
Advance directives | ||||||||||
Adequately aware of advance directives Q3 | 72 31.9% | 36 22.0% | 76 46.9% | 32 14.0% | 33 27.0% | 75 28.0% | 52 48.6% | 56 19.8% | 68 23.4% | 40 40.4% |
Crude OR* | 1.66 (1.05–2.64) | 5.26 (3.33–9.09) | 0.95 (0.59–1.54) | 3.83 (2.37–6.19) | 0.45 (0.28–0.73) | |||||
Adjusted OR** | – | 4.15 (2.49–6.94) | – | 2.34 (1.39–3.94) | – | |||||
Withholding/withdrawing life-sustaining treatment | ||||||||||
Favours not placing a metastatic cancer patient on ventilator Q6 | 120 53.1% | 81 49.4% | 107 66.0% | 94 41.2% | 57 46.7% | 144 53.7% | 66 61.7% | 135 47.7% | 142 48.8% | 59 59.6% |
Crude OR* | 1.16 (0.78–1.74) | 2.77 (1.83–4.22) | 0.75 (0.49–1.16) | 1.76 (1.12–2.78) | 0.65 (0.41–1.03) | |||||
Adjusted OR** | – | 2.77 (1.83–4.22) | – | – | – | |||||
Favours disconnecting a brain-dead patient from ventilator Q7 | 194 85.8% | 139 84.8% | 132 81.5% | 201 88.2% | 96 78.7% | 237 88.4% | 85 79.4% | 248 87.6% | 249 85.6% | 84 84.8% |
Crude OR* | 1.09 (0.62–1.92) | 0.59 (0.34–1.04) | 0.48 (0.27–0.86) | 0.55 (0.3–0.98) | 1.06 (0.56–2.01) | |||||
Adjusted OR** | – | – | 0.49 (0.28–0.88) | – | – | |||||
Knows that time of death is the time of brain death Q8 | 38 16.8% | 19 11.6% | 34 21.0% | 23 10.1% | 22 18.0% | 35 13.1% | 20 18.7% | 37 13.1% | 43 14.8% | 14 14.1% |
Crude OR* | 1.54 (0.85–2.79) | 2.37 (1.33–4.2) | 1.47 (0.82–2.62) | 1.53 (0.84–2.78) | 1.05 (0.55–2.02) | |||||
Adjusted OR** | – | 2.37 (1.33–4.2) | – | – | – | |||||
More comfortable withholding than withdrawing ventilation Q9 | 160 70.8% | 114 69.5% | 118 72.8% | 156 68.4% | 97 79.5% | 177 66.0% | 81 75.7% | 193 68.2% | 206 70.8% | 68 68.7% |
Crude OR* | 1.06 (0.69–1.65) | 1.24 (0.79–1.93) | 1.99 (1.2–3.31) | 1.45 (0.87–2.41) | 1.11 (0.67–1.81) | |||||
Adjusted OR** | – | – | 1.99 (1.2–3.31) | – | – | |||||
DNACPR | ||||||||||
Adequately aware of DNACPR Q10 | 147 65.0% | 88 53.7% | 105 64.8% | 130 57.0% | 86 70.5% | 149 55.6% | 75 70.1% | 160 56.5% | 170 58.4% | 65 65.7% |
Crude OR* | 1.61 (1.07–2.42) | 1.39 (0.92–2.11) | 1.91 (1.21–3.02) | 1.8 (1.12–2.9) | 0.74 (0.46–1.18) | |||||
Adjusted OR** | – | – | 1.76 (1.11–2.81) | – | – | |||||
Aware when to consider DNACPR Q11 | 53 23.5% | 32 19.5% | 44 27.2% | 41 18.0% | 33 27.0% | 52 19.4% | 36 33.6% | 49 17.3% | 67 23.0% | 18 18.2% |
Crude OR* | 1.26 (0.77–2.07) | 1.7 (1.05–2.76) | 1.54 (0.93–2.54) | 2.42 (1.46–4.02) | 1.35 (0.75–2.4) | |||||
Adjusted OR** | – | – | – | 2.48 (1.49–4.14) | – | |||||
Aware that the medical team makes the DNACPR decision in an unconscious patient Q12 | 45 19.9% | 31 18.9% | 30 18.5% | 46 20.2% | 20 16.4% | 56 20.9% | 24 22.4% | 52 18.4% | 51 17.5% | 25 25.3% |
Crude OR* | 1.07 (0.64–1.78) | 0.89 (0.54–1.49) | 0.74 (0.42–1.3) | 1.29 (0.75–2.22) | 0.63 (0.37–1.09) | |||||
Adjusted OR** | – | – | – | – | – | |||||
Knows that DNACPR does not entail withdrawing life-sustaining treatment Q13 | 152 67.3% | 96 58.5% | 107 66.0% | 141 61.8% | 89 73.0% | 159 59.3% | 78 72.9% | 170 60.1% | 190 65.3% | 58 58.6% |
Crude OR* | 1.46 (0.96–2.21) | 1.2 (0.79–1.83) | 1.85 (1.16–2.95) | 1.79 (1.1–2.92) | 1.33 (0.83–2.12) | |||||
Adjusted OR** | – | – | 1.74 (1.08–2.79) | 1.84 (1.1–3.06) | – | |||||
No reluctance to make DNACPR decision Q14 | 153 67.7% | 89 54.3% | 114 70.4% | 128 56.1% | 81 66.4% | 161 60.1% | 77 72.0% | 165 58.3% | 181 62.2% | 61 61.6% |
Crude OR* | 1.77 (1.17–2.67) | 1.86 (1.21–2.84) | 1.31 (0.84–2.05) | 1.83 (1.13–2.98) | 1.02 (0.64–1.64) | |||||
Adjusted OR** | 1.64 (1.08–2.5) | 1.74 (1.13–2.68) | – | – | – |